FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to a method for producing a peptide with modified lysine side chain. The invention discloses a method for producing exendin-4 analogue modified with lipophilic substituent by amino acid lysine residue using solid-phase peptide synthesis.
EFFECT: described method for producing the modified peptide using certain sequence of stages allows for significant reduction in amount of unwanted side products and increase in target product yield.
13 cl, 14 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE | 2019 |
|
RU2771712C2 |
SYNTHESIS OF LIXISENATIDE WITH CAPPING | 2019 |
|
RU2782772C2 |
METHOD FOR THERAPEUTIC PEPTIDES SYNTHESIS | 2012 |
|
RU2625793C2 |
SACCHARIDE CHAIN-POLYPEPTIDE COMPLEXES | 2014 |
|
RU2664539C2 |
NOVEL METHODS OF PRODUCING BARUSIBAN AND INTERMEDIATE COMPOUNDS THEREOF | 2016 |
|
RU2726414C2 |
METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | 2013 |
|
RU2652783C2 |
METHOD OF PRODUCING PEPTIDE | 2008 |
|
RU2478105C2 |
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2624034C2 |
PRODRUG CONTAINING A SELF-CLEAVABLE LINKER | 2018 |
|
RU2798085C2 |
Authors
Dates
2021-09-17—Published
2017-10-10—Filed